| Literature DB >> 22163899 |
Stefan Sinn1, Mirjam Eichler, Lothar Müller, Daniel Bünger, Jürgen Groll, Gerhard Ziemer, Frank Rupp, Hinnak Northoff, Jürgen Geis-Gerstorfer, Frank K Gehring, Hans P Wendel.
Abstract
The reliability of implantable blood sensors is often hampered by unspecific adsorption of plasma proteins and blood cells. This not only leads to a loss of sensor signal over time, but can also result in undesired host vs. graft reactions. Within this study we evaluated the hemocompatibility of isocyanate conjugated star shaped polytheylene oxide-polypropylene oxide co-polymers NCO-sP(EO-stat-PO) when applied to gold surfaces as an auspicious coating material for gold sputtered blood contacting sensors. Quartz crystal microbalance (QCM) sensors were coated with ultrathin NCO-sP(EO-stat-PO) films and compared with uncoated gold sensors. Protein resistance was assessed by QCM measurements with fibrinogen solution and platelet poor plasma (PPP), followed by quantification of fibrinogen adsorption. Hemocompatibility was tested by incubation with human platelet rich plasma (PRP). Thrombin antithrombin-III complex (TAT), β-thromboglobulin (β-TG) and platelet factor 4 (PF4) were used as coagulation activation markers. Furthermore, scanning electron microscopy (SEM) was used to visualize platelet adhesion to the sensor surfaces. Compared to uncoated gold sensors, NCO-sP(EO-stat-PO) coated sensors revealed significant better resistance against protein adsorption, lower TAT generation and a lower amount of adherent platelets. Moreover, coating with ultrathin NCO-sP(EO-stat-PO) films creates a cell resistant hemocompatible surface on gold that increases the chance of prolonged sensor functionality and can easily be modified with specific receptor molecules.Entities:
Keywords: QCM; biosensors; hemocompatibility; protein adsorption; surface coating
Mesh:
Substances:
Year: 2011 PMID: 22163899 PMCID: PMC3231391 DOI: 10.3390/s110505253
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1.Protein adsorption measured by QCM with fibrinogen solution (0.5 mg/mL, in PBS, pH 7.4) (A) and diluted human plasma (1 + 4 diluted in PBS, pH 7.4) (B).
Figure 2.QCM frequency changes during protein adsorption measurements. NCO-sP(EO-stat-PO) coated and uncoated gold sensors were incubated in the QCM device with fibrinogen solution and 1 + 4 diluted human PPP (n = 3, for each Group). Differences between groups were calculated by univariate analysis of variance. Values of p < 0.05 were considered as significant and marked with *.
Figure 3.Modified ELISA tests for fibrinogen adsorption from 0.5 mg/mL fibrinogen solution (A) und 1 + 4 diluted human PPP (B). Differences between groups were calculated by univariate analysis of variance (n = 3 for each group). Values of p < 0.05 were considered as significant and marked with *.
Figure 4.Plasma concentration of coagulation marker thrombin antithrombin complex (TAT). Before (t0) and after 60 min of PRP incubation on the rocking platform. Samples without sensors (ctrl.), with NCO-sP(EO-stat-PO) coated sensors (NCO-sP(EO-stat-PO)) and uncoated gold sensors (Gold). For each group 3 samples (n = 3) were tested.
Figure 5.Plasma concentrations platelet activation markers. ELISA tests for β-thromboglobulin (A) and platelet factor 4 (B). Before (t0) and after 60 min of PRP incubation on the rocking platform, Sample without sensors (ctrl.), with NCO-sP(EO-stat-PO) coated sensors (NCO-sP(EO-stat-PO)) and uncoated gold sensors (Gold) each group 3 samples (n = 3) were tested.
Static contact angle measurements on uncoated gold sensors and NCO-sP (EO-stat-PO) coated sensors.
| Gold | 69 ± 1.4 |
| NCO-sP(EO- | 22 ± 4.7 |
Determination of layer thickness and homogeneity of the coatings with ellipsometry.
| NCO-sP(EO- | 19.6 ± 0.4 |
| NCO-sP(EO- | 24.4 ± 1.0 |
| NCO-sP(EO- | 12.0 ± 0.8 |
Figure 6.Scanning electron microscopic images of NCO-sP(EO-stat-PO) coated sensors (A) and (B) and uncoated gold sensors (C) and (D).